TUESDAY, Oct. 28, 2025 (HealthDay News) -- The U.S. Food and Drug Administration approved Tezspire (tezepelumab-ekko; Amgen) for the add-on maintenance treatment of inadequately controlled chronic ...
Tezspire is the first biologic approved for CRSwNP targeting TSLP, expanding its respiratory indications. The drug acts on airway epithelium, inhibiting TSLP, an early-stage inflammatory cytokine. The ...
DelveInsight’s “Chronic Rhinosinusitis with Nasal Polyps Pipeline Insight 2025” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in the Chronic Rhinosinusitis with ...
If you have nasal polyps, you likely deal with a range of symptoms, including nasal congestion, loss of smell and taste, and facial pain and pressure. To treat those symptoms, your doctor may have ...
When Today in Ohio host Laura Johnston turned 45 this year, she faced a medical milestone many dread: her first colonoscopy. Her candid discussion about the experience on the cleveland.com and Plain ...
A surgeon speaks with a patient about colon cancer screening. (Photo courtesy of the U.S. Navy) Just saying the word colonoscopy makes some people feel uncomfortable. But consider this: Colorectal ...
A team of Norwegian researchers, through international collaboration, found that the use of artificial intelligence (AI) during colonoscopy increased the detection of polyps by about 8%, but the risk ...
DEAR DR. ROACH: I am a 71-year-old male who is a nonsmoker and a social drinker. Other than a statin, I am not taking any medications. I have been getting colonoscopies every five years as each time ...
Dear Dr. Roach: I am a 71-year-old male who is a nonsmoker and a social drinker. Other than a statin, I am not taking any medications. I have been getting colonoscopies every five years as each time ...
The frequency of colorectal polyp diagnosis in relatives is linked to an increased risk of colorectal cancer, especially early-onset colorectal cancer, independent of the number of close relatives ...
AI can increase adenoma detection rates by 10-15%, enhancing colonoscopy effectiveness in reducing colorectal cancer risk. Higher adenoma detection rates correlate with lower interval colorectal ...
SAN DIEGO -- Tezepelumab (Tezspire) reduced nasal polyps and symptoms in severe chronic rhinosinusitis while also decreasing need for further treatments, the WAYPOINT trial showed. The monoclonal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback